Vertex Pharmaceuticals Incorporated announced, Dr. Reshma Kewalramani became the President and Chief Executive Officer of the Company and Dr. Jeffrey M. Leiden transitioned to the role of Executive Chairman of the Company, in each case, effective April 1, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
401.1 USD | +0.23% | +0.91% | -1.43% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals Incorporated Announces Executive Changes